Onderzoeker
Ivan Van Riet
- Onderzoeksexpertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
- Trefwoorden:Geneeskunde
- Disciplines:Landbouwwetenschappen, diergeneeskunde en levensmiddelenwetenschappen, Sociale wetenschappen, Natuurwetenschappen
- Gebruikers van onderzoeksexpertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Affiliaties
- Hematologie (Departement)
Lid
Vanaf1 jun 2010 → Heden - Hematologie (Onderzoeksgroep)
Lid
Vanaf1 okt 1999 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 20 okt 2022 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 2005 → 31 dec 2013 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 2002 → 30 sep 2005 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 sep 1992 → 31 aug 1993
Projecten
1 - 2 of 2
- Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsiesVanaf1 nov 2021 → HedenFinanciering: FWO junior postdoctoraal mandaat
- Tumor-microomgeving interacties in multiple myeloom: regulatie door epigenetische veranderingen en hypoxie.Vanaf1 jan 2010 → 31 dec 2013Financiering: FWO Onderzoeksproject (incl. WEAVE projecten)
Publicaties
1 - 10 van 20
- Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma(2024)
Auteurs: Jens Tijtgat, Xenia Geeraerts, Anais Boisson, Latoya Stevens, Manon Vounckx, Iris Dirven, Julia Katharina Schwarze, Steven Raeymaeckers, Ramses G Forsyth, Ivan Van Riet, et al.
- Influence of in vitro expansion conditions on biological properties of bone marrow-derived mesenchymal stromal cells(2023)
Auteurs: Ann De Becker, Ivan Van Riet
Aantal pagina's: 170 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Auteurs: Julia Katharina Schwarze, Jens Tijtgat, G Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses G Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pagina's: 1-13 - Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells(2022)
Auteurs: Philipp Kalus, Jolien De Munck, Sarah Vanbellingen, Laura Carreer, Thessa Laeremans, Katrijn Broos, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Bart Neyns, et al.
- Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells(2021)
Auteurs: Jens Tijtgat, Jolien De Munck, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Lorenzo Franceschini, Karine Breckpot, Joeri L Aerts, Bart Neyns, Sandra Tuyaerts
- Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Auteurs: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pagina's: 599-611 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Auteurs: Julia Katharina Schwarze, G Awada, Louise Cras, Jens Tijtgat, Ramses G Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pagina's: 1-16 - Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.(2019)
Auteurs: HA Poirel, Marijke Vanspauwen, Gilles Macq, Anke De Geyndt, Johan Maertens, Evelyne Willems, Dominik Selleslag, X Poiré, Koen Theunissen, Carlos Graux, et al.
Pagina's: 1434-1442 - Mesenchymal stem cells in multiple myeloma(2018)
Auteurs: Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken, Ivan Van Riet
Pagina's: 1500-1514 - Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity(2016)
Auteurs: Kim De Veirman, Jinheng Wang, Song Xu, Xavier Leleu, Eddy Himpe, Ken Maes, Elke De Bruyne, E Van Valckenborgh, Karin Vanderkerken, Eline Menu, et al.
Pagina's: 17-24